Study of 131 organizing pneumonia (OP) pts compared autoimmune related (AIRD-OP) to cryptogenic OP and found 2/3 of AIRD-OP presented w/ OP at Dz onset, had more severe lung Dz & higher recurrence rates; Associated with Sjogrens, PM/DM, RA. T https://t.co/uKTUFDYub4

Among 2619 RA patients, use of hydroxychloroquine (n 1212) was associated with a lower risk of CKD (10.3 vs 13.8 per 1000PY); thus HCQ assoc w/ a lower risk of incident CKD (HZ 0.64; 95% confidence interval, 0.45 to 0.90; P=0.01) & was dose dependent https://t.co/MaTsZEDBKG

125 SLE pts were hospitalized w/ 187 serious infxn. Pulmonary (37.9%), sepsis (22.5%) & Gram-negatives (38.2%) predominated. Predictors of Infx-related mortality- SLE flare (HR 3.98) & bacteremia (HR 2.54); HCQ was protective of infx mortality (HR 9.26). https://t.co/XHGRVGWTJt

FDA Arthritis advisory panel voting on baricitinib safety was 9-6 in favor of 2mg and was 11-4 against the safety of 4 mg

FDA Arthritis advisory panel voting in progress. Early votes unanimously in favor of baricitinib efficacy at 4 mg (15-0) or 2mg(14-1 unfavorably)